SS Innovations International Inc.?(NASDAQ: SSII) Reports Strong Q1 2026 Results with Surgical Robotics Expansion

• 1d
• 5d
• 1m
• 3m
• 6m
• 1y
• 5y

2026-06-29 09:50:00 ET

• SS Innovations reported record first-quarter 2026 revenue of $11.1 million, up 116.8% year over year, driven by growing adoption of its SSi Mantra surgical robotic system.
• The installed base reached 194 SSi Mantra systems across 11 countries, with nearly 9,750 cumulative robotic procedures completed.
• Regulatory approvals in Sri Lanka, Kenya, Indonesia, and the Philippines, expanded the company's international market access during the quarter.
• SS Innovations recently completed the world's longest-distance robotic cardiac telesurgery in history, demonstrating the capabilities of its remote surgery platform.
• The company continues pursuing regulatory clearance in both the United States and Europe while expanding its presence in emerging healthcare markets.

SS Innovations International (NASDAQ: SSII) , a developer of innovative surgical robotic technologies to aid in cardiac and other surgeries, including telesurgeries, reported record first-quarter 2026 financial results, highlighting accelerating commercial adoption of its SSi Mantra surgical robotic platform as the company continues expanding internationally and pursuing regulatory approvals in major healthcare markets.

According to the company's first-quarter earnings announcement, revenue increased 116.8% year over year to $11.1 million, driven primarily by higher installations of the SSi Mantra surgical robotic system and increased procedure volumes. Gross profit rose to $5.3 million from $1.1 million a year earlier, while…

Read More>>

For more information, visit the company's website at https://www.SSInnovations.com .

Update:

As of June 22, 2026, the cumulative number of multi-specialty procedures completed with the SSi Mantra surgical robotic system totaled 11,719, including 612 cardiac procedures, 175 telesurgeries, and 212 pediatric surgeries. Additionally, approximately 2,100 physicians have been trained on the SSi Mantra, which has been utilized to perform over 170 different types of procedures.

About InvestorWire

InvestorWire ("IW") is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers : (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]

InvestorWire is powered by IBN